Growth Metrics

Sanofi (SNY) Non-cash Items (2016 - 2025)

Sanofi's Non-cash Items history spans 17 years, with the latest figure at $4.5 billion for Q2 2025.

  • On a quarterly basis, Non-cash Items rose 15.95% to $4.5 billion in Q2 2025 year-over-year; TTM through Jun 2025 was $4.5 billion, a 15.95% increase, with the full-year FY2023 number at $10.3 billion, down 13.25% from a year prior.
  • Non-cash Items hit $4.5 billion in Q2 2025 for Sanofi, up from $3.9 billion in the prior quarter.
  • Over the last five years, Non-cash Items for SNY hit a ceiling of $11.5 billion in Q4 2022 and a floor of $3.9 billion in Q2 2024.
  • Historically, Non-cash Items has averaged $6.9 billion across 5 years, with a median of $5.1 billion in 2021.
  • Biggest five-year swings in Non-cash Items: soared 18949.42% in 2021 and later fell 18.57% in 2024.
  • Tracing SNY's Non-cash Items over 5 years: stood at $10.4 billion in 2021, then rose by 9.93% to $11.5 billion in 2022, then dropped by 10.87% to $10.2 billion in 2023, then crashed by 61.96% to $3.9 billion in 2024, then increased by 15.95% to $4.5 billion in 2025.
  • Business Quant data shows Non-cash Items for SNY at $4.5 billion in Q2 2025, $3.9 billion in Q2 2024, and $10.2 billion in Q4 2023.